Comparison 1. Endothelin receptor antagonist versus placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 DIND | 3 | 1976 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.80 [0.67, 0.95] |
2 Mortality | 4 | 2010 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.05 [0.77, 1.45] |
3 Angiographic vasospasm | 3 | 1588 | Risk Ratio (M‐H, Random, 95% CI) | 0.62 [0.52, 0.72] |
4 Unfavorable outcome | 3 | 1976 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.87 [0.74, 1.02] |
5 Hypotension | 4 | 2008 | Risk Ratio (M‐H, Fixed, 95% CI) | 2.53 [1.77, 3.62] |
6 Pneumonia | 3 | 1976 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.56 [1.23, 1.97] |